• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉-口服抗生素转换治疗:重症监护病房的横断面研究。

Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units.

机构信息

School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.

Laboratory of Emerging Infectious Diseases, Escola de Medicina, Pontifícia Universidade Católica do Paraná, Rua Imaculada Conceição, 1155, Curitiba, PR, 80215-901, Brazil.

出版信息

BMC Infect Dis. 2019 Jul 22;19(1):650. doi: 10.1186/s12879-019-4280-0.

DOI:10.1186/s12879-019-4280-0
PMID:31331272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6647098/
Abstract

BACKGROUND

This study aimed to evaluate the oral switch (OS) stewardship intervention in the intensive care unit (ICU).

METHODS

This was a retrospective study with a convenience sample in two Brazilian ICUs from different hospitals in patients with sepsis receiving antibiotic therapy. The stewardship intervention included OS in patients diagnosed with sepsis when clinical stability was achieved. The primary outcome was overall mortality. Other variables evaluated were as follows: cost of antimicrobial treatment, daily costs of intensive care, acute kidney injury, and length of stay.

RESULTS

There was no difference in mortality between the OS and non-OS groups (p = 0.06). Length of stay in the ICU (p = 0.029) was shorter and acute kidney injury incidence (p = 0.032) and costs of antimicrobial therapy (p < 0.001) were lower in the OS group.

CONCLUSION

OS stewardship programs in the ICU may be considered a safe strategy. Switch therapy reduced the cost and shortened the length of stay in ICUs.

摘要

背景

本研究旨在评估重症监护病房(ICU)中的口服转换(OS)管理干预措施。

方法

这是一项回顾性研究,采用便利抽样法,选取了来自巴西两家不同医院的 ICU 中接受抗生素治疗的脓毒症患者。管理干预措施包括在临床稳定时诊断为脓毒症的患者中进行 OS。主要结局为总体死亡率。评估的其他变量如下:抗菌治疗的成本、重症监护的日费用、急性肾损伤和住院时间。

结果

OS 组和非 OS 组之间的死亡率无差异(p=0.06)。OS 组 ICU 住院时间(p=0.029)更短,急性肾损伤发生率(p=0.032)和抗菌治疗费用(p<0.001)更低。

结论

ICU 中的 OS 管理计划可能被认为是一种安全的策略。转换治疗降低了 ICU 的成本并缩短了住院时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/6647098/fa4f42b0ae18/12879_2019_4280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/6647098/fa4f42b0ae18/12879_2019_4280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/6647098/fa4f42b0ae18/12879_2019_4280_Fig1_HTML.jpg

相似文献

1
Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units.静脉-口服抗生素转换治疗:重症监护病房的横断面研究。
BMC Infect Dis. 2019 Jul 22;19(1):650. doi: 10.1186/s12879-019-4280-0.
2
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.快速诊断与抗菌药物管理的整合可改善抗生素耐药革兰氏阴性菌血症患者的结局。
J Infect. 2014 Sep;69(3):216-25. doi: 10.1016/j.jinf.2014.05.005. Epub 2014 May 17.
3
Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.与基于药效动力学的呼吸机相关性肺炎经验性抗生素选择临床路径相关的住院时间和住院费用。
Pharmacotherapy. 2010 May;30(5):453-62. doi: 10.1592/phco.30.5.453.
4
Impact of the implementation of a Sepsis Code hospital protocol in antibiotic prescription and clinical outcomes in an intensive care unit.脓毒症代码医院协议的实施对重症监护病房抗生素处方及临床结局的影响。
Med Intensiva. 2017 Jan-Feb;41(1):12-20. doi: 10.1016/j.medin.2016.08.001. Epub 2016 Oct 19.
5
Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia.医院获得性大肠杆菌菌血症的重症患者不存在额外死亡率。
Infect Control Hosp Epidemiol. 2003 Dec;24(12):912-5. doi: 10.1086/502159.
6
Factors influencing antibiotic treatment cost and outcome in critically ill patients: a "real-life" study.影响重症患者抗生素治疗成本和结局的因素:一项“真实世界”研究
Vojnosanit Pregl. 2014 Dec;71(12):1102-8. doi: 10.2298/vsp1412102p.
7
A nationwide survey of intravenous antimicrobial use in intensive care units in Japan.日本重症监护病房静脉内抗菌药物使用的全国性调查。
Int J Antimicrob Agents. 2018 Apr;51(4):636-641. doi: 10.1016/j.ijantimicag.2018.01.022. Epub 2018 Feb 2.
8
Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.脓毒症分类和多重耐药状态对接受适当治疗患者预后的影响。
Crit Care Med. 2015 Aug;43(8):1580-6. doi: 10.1097/CCM.0000000000001013.
9
7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial.血流感染重症患者接受7天与14天抗生素治疗的比较:一项前瞻性随机临床试验
Trials. 2018 Feb 17;19(1):111. doi: 10.1186/s13063-018-2474-1.
10
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.菌血症临床疗效所需抗生素实际疗程(BALANCE):一项初步随机对照试验的研究方案
Trials. 2015 Apr 18;16:173. doi: 10.1186/s13063-015-0688-z.

引用本文的文献

1
Economic Impact in the Treatment of Coagulase-Negative Staphylococci Blood Cultures Contamination in a Middle-Income Country.中等收入国家凝固酶阴性葡萄球菌血培养污染治疗中的经济影响
Rev Soc Bras Med Trop. 2025 Aug 8;58:e00942025. doi: 10.1590/0037-8682-0094-2025. eCollection 2025.
2
Barriers to Compliance with National Guidelines Among Children Hospitalized with Community-Acquired Pneumonia in Vietnam and the Implications.越南社区获得性肺炎住院儿童遵守国家指南的障碍及影响
Antibiotics (Basel). 2025 Jul 15;14(7):709. doi: 10.3390/antibiotics14070709.
3
Enteral versus intravenous antibiotics for critically ill patients: A pilot study.

本文引用的文献

1
Vancomycin trough level and loading dose.万古霉素谷浓度及负荷剂量。
Infect Drug Resist. 2018 Nov 23;11:2393-2396. doi: 10.2147/IDR.S184897. eCollection 2018.
2
Polymyxin B and colistin-the economic burden of nephrotoxicity against multidrug resistant bacteria.多粘菌素B和黏菌素——针对多重耐药菌的肾毒性的经济负担
J Med Econ. 2019 Feb;22(2):158-162. doi: 10.1080/13696998.2018.1552431. Epub 2018 Dec 13.
3
Acute kidney injury in patients using low dose (3 mg/kg/day) of gentamicin under therapeutic dose monitoring.在治疗剂量监测下使用低剂量(3毫克/千克/天)庆大霉素的患者发生急性肾损伤。
危重症患者肠内与静脉使用抗生素的比较:一项初步研究。
Braz J Infect Dis. 2025 May 14;29(4):104538. doi: 10.1016/j.bjid.2025.104538.
4
Antimicrobial Use Among Hospitalized Neonates and Children; Findings and Implications from a Comprehensive Point Prevalence Survey Among General Tertiary Hospitals in Pakistan.巴基斯坦综合三级医院住院新生儿和儿童的抗菌药物使用情况;全面现患率调查结果及启示
Infect Drug Resist. 2024 Dec 6;17:5411-5428. doi: 10.2147/IDR.S491454. eCollection 2024.
5
eHealth and mHealth in Antimicrobial Stewardship Programs.抗菌药物管理计划中的电子健康与移动健康
Digit Biomark. 2024 Sep 20;8(1):194-206. doi: 10.1159/000541120. eCollection 2024 Jan-Dec.
6
Market concentration of the Brazilian hospital medical supplementary health system.巴西医院医疗补充健康系统的市场集中
BMC Health Serv Res. 2024 Oct 16;24(1):1244. doi: 10.1186/s12913-024-11280-w.
7
eHealth and mHealth in Antimicrobial Stewardship to Reduce Mortality in Empirical Antimicrobial Therapy and a Systematic Review with a Meta-Analysis of Adequate Therapy.电子健康和移动健康在抗菌药物管理中的应用,以降低经验性抗菌治疗的死亡率及一项关于充分治疗的系统评价与荟萃分析
Infect Dis Rep. 2024 Aug 1;16(4):707-723. doi: 10.3390/idr16040054.
8
Continued Intravenous Versus First Week Transition to Oral Antibiotic Therapy in Bloodstream Infections: A Systematic Review and Meta-Analysis.血流感染中持续静脉注射与首周过渡至口服抗生素治疗的比较:一项系统评价和荟萃分析
Cureus. 2024 Jul 24;16(7):e65298. doi: 10.7759/cureus.65298. eCollection 2024 Jul.
9
Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation.应对革兰氏阴性菌中的氟喹诺酮耐药性:全面评估
JAC Antimicrob Resist. 2024 Aug 14;6(4):dlae127. doi: 10.1093/jacamr/dlae127. eCollection 2024 Aug.
10
Assessment of frequency and types of drug interactions in intensive care units: a cross-sectional study.重症监护病房药物相互作用的频率和类型评估:一项横断面研究。
Ann Med Surg (Lond). 2023 Nov 1;86(1):98-102. doi: 10.1097/MS9.0000000000001355. eCollection 2024 Jan.
J Infect. 2018 May;76(5):496-498. doi: 10.1016/j.jinf.2018.01.008. Epub 2018 Jan 31.
4
Mobile health application to assist doctors in antibiotic prescription - an approach for antibiotic stewardship.协助医生进行抗生素处方的移动健康应用程序——一种抗生素管理方法。
Braz J Infect Dis. 2017 Nov-Dec;21(6):660-664. doi: 10.1016/j.bjid.2017.08.002. Epub 2017 Sep 21.
5
Antimicrobial Stewardship Approaches in the Intensive Care Unit.重症监护病房的抗菌药物管理方法
Infect Dis Clin North Am. 2017 Sep;31(3):513-534. doi: 10.1016/j.idc.2017.05.002. Epub 2017 Jul 5.
6
The AKI glossary.急性肾损伤术语表。
Intensive Care Med. 2017 Jun;43(6):893-897. doi: 10.1007/s00134-017-4751-y. Epub 2017 Apr 1.
7
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units.在重症监护病房实施抗菌药物管理计划的成本效益分析。
J Med Econ. 2017 Jun;20(6):652-659. doi: 10.1080/13696998.2017.1311903. Epub 2017 Apr 13.
8
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.成人医院获得性肺炎和呼吸机相关性肺炎的管理:美国感染病学会和美国胸科学会2016年临床实践指南
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
9
Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria.在耐碳青霉烯类细菌时代使用阿米卡星的患者中的急性肾损伤
Infect Dis (Lond). 2016 Nov-Dec;48(11-12):869-71. doi: 10.1080/23744235.2016.1205215. Epub 2016 Jul 8.
10
Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.当前医院抗菌药物管理目标的证据:系统评价和荟萃分析。
Lancet Infect Dis. 2016 Jul;16(7):847-856. doi: 10.1016/S1473-3099(16)00065-7. Epub 2016 Mar 3.